Articles
Pint of Science Festival
Heloïse Tudela, PhD in the Team 3 will talk about Microbiome.
11th may, 7pm @Levrette Café, Bordeaux.
Book here!
Conferences :
September 2022:
Maya Saleh organizes and participates to the “9th Immunotherapy of Cancer Conference” in Munich, Germany
PhD defences :
24/03/2022 : Corentin Le-Saos—Patrinos
« L’implication des lymphocytes T folliculaires helper dans la leucémie lymphoïde chronique »
Supervisor : Dorothée Duluc
Jury : Yves renaudineau, Pierre Milpied, Pierre Soubeyran,Patricia Amé.
28/03/2022 : Adrien Duran
« Pathogénicité des lymphocytes dérivés de l’intestin dans la sclérose en plaques»
Supervisor : Nathalie Schmitt
Ma thèse en 180 secondes
Ribal MEHRI, doctorant d’ImmunoConcEpT en Demi-finale 2022 du concours Ma Thèse en 180s
3 mars 2022 – 13 h45 Agora – domaine du Haut-Carré – Université de Bordeaux, 43 rue Pierre Noailles à Talence
MEHRI Ribal
Doctorant en immunologie
École doctorale : Sciences de la vie et de la santé
Laboratoire : Immunologie conceptuelle, expérimentale et translationnelle (Immunoconcept)
Thèse : Impact de médiateurs inflammatoires sur la perte de mélanocytes au cours du vitiligo
https://www.u-bordeaux.fr/Evenements/De-la-vie-de-campus/Demi-finale-2022-du-concours-Ma-These-en-180s
Redrawing therapeutic boundaries: microbiota and cancer
by Jonathan Sholl, Gregory D.Sepich-Poore, Rob Knight & Thomas Pradeu
Published: November 26, 2021 in Trends in Cancer
https://doi.org/10.1016/j.trecan.2021.10.008
Summary
The unexpected roles of the microbiota in cancer challenge explanations of carcinogenesis that focus on tumor-intrinsic properties. Most tumors contain bacteria and viruses, and the host’s proximal and distal microbiota influence both cancer incidence and therapeutic responsiveness. Continuing the history of cancer–microbe research, these findings raise a key question: to what extent is the microbiota relevant for clinical oncology? We approach this by critically evaluating three issues: how the microbiota provides a predictive biomarker of cancer growth and therapeutic responsiveness, the microbiota’s causal role(s) in cancer development, and how therapeutic manipulations of the microbiota improve patient outcomes in cancer. Clarifying the conceptual and empirical aspects of the cancer-associated microbiota can orient future research and guide its implementation in clinical oncology.
ImmunoConcEpt laureates Part III: Corentin Le Saos-Patrinos
Corentin Le Saos-Patrinos’s talk selected as the best oral communication, at the Scientific Day of the Departement Sciences Biologiques et Médicales.
More infos about the SBM Dept here.
ImmunoConcEpt laureates Part II: Domitile Chalopin @EMBL
Domitile Chalopin, post-doc in the group of Maya Saleh, will be a SPEAKER and SESSION CHAIR at the “EMBL Cancer Genomics Symposium”:
https://www.embl.org/about/info/course-and-conference-office/events/can21-01/
Congratulations!